Jake Samuel Burrell1, Jane Halliday2,
Simon Walker-Samuel3, John C. Waterton2, Jessica Boult1,
Yann Jamin1, Lauren C. Baker1, Simon P. Robinson1
1The Institute of Cancer Research,
Sutton, Surrey, United Kingdom; 2AstraZeneca, Manchester, United
Kingdom; 3UCL, London, United Kingdom
Tumour
vascular morphology and function is dependent on both tumour size and site of
implantation. Perturbation of tissue R2* by carbogen gas (95% O2,
5% CO2) breathing, or ultra small paramagnetic iron oxide (USPIO) particle
injection offers biomarkers for tumour oxygenation, and blood volume
respectively. Using a combined carbogen USPIO imaging protocol, tumour
δR2* during carbogen breathing, and after injection of USPIO
particles was found to be significantly different in small and large
subcutaneous, and orthotopic PC3 prostate tumours. This has implications when
considering both drug delivery, and extent of tumour oxygenation during drug
trials